Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.

Research output: Contribution to journalArticle

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Surgery
Original languageEnglish
Pages (from-to)1325-1331
JournalBiochemical Pharmacology
Volume69
Issue number9
Publication statusPublished - 2005
Publication categoryResearch
Peer-reviewedYes